Cargando…
Short-Term Therapies for Treatment of Acute and Advanced Heart Failure—Why so Few Drugs Available in Clinical Use, Why Even Fewer in the Pipeline?
Both acute and advanced heart failure are an increasing threat in term of survival, quality of life and socio-economical burdens. Paradoxically, the use of successful treatments for chronic heart failure can prolong life but—per definition—causes the rise in age of patients experiencing acute decomp...
Autores principales: | Pollesello, Piero, Ben Gal, Tuvia, Bettex, Dominique, Cerny, Vladimir, Comin-Colet, Josep, Eremenko, Alexandr A., Farmakis, Dimitrios, Fedele, Francesco, Fonseca, Cândida, Harjola, Veli-Pekka, Herpain, Antoine, Heringlake, Matthias, Heunks, Leo, Husebye, Trygve, Ivancan, Visnja, Karason, Kristjan, Kaul, Sundeep, Kubica, Jacek, Mebazaa, Alexandre, Mølgaard, Henning, Parissis, John, Parkhomenko, Alexander, Põder, Pentti, Pölzl, Gerhard, Vrtovec, Bojan, Yilmaz, Mehmet B., Papp, Zoltan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912236/ https://www.ncbi.nlm.nih.gov/pubmed/31683969 http://dx.doi.org/10.3390/jcm8111834 |
Ejemplares similares
-
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use
por: Papp, Zoltán, et al.
Publicado: (2020) -
Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use
por: Papp, Zoltán, et al.
Publicado: (2020) -
Haemodynamic Balance in Acute and Advanced Heart Failure: An Expert Perspective on the Role of Levosimendan
por: Agostoni, Piergiuseppe, et al.
Publicado: (2019) -
Levosimendan in Acute and Advanced Heart Failure: An Appraisal of the Clinical Database and Evaluation of Its Therapeutic Applications
por: Altenberger, Johann, et al.
Publicado: (2018) -
Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic Application
por: Bouchez, S., et al.
Publicado: (2018)